Elena Pentsova

5.2k total citations
67 papers, 1.5k citations indexed

About

Elena Pentsova is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Elena Pentsova has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Genetics, 39 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Elena Pentsova's work include Glioma Diagnosis and Treatment (37 papers), Brain Metastases and Treatment (35 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Elena Pentsova is often cited by papers focused on Glioma Diagnosis and Treatment (37 papers), Brain Metastases and Treatment (35 papers) and CNS Lymphoma Diagnosis and Treatment (15 papers). Elena Pentsova collaborates with scholars based in United States, Switzerland and Austria. Elena Pentsova's co-authors include Lisa M. DeAngelis, Adrienne Boire, Antonio Omuro, Joan Massagué, Danilo G. Macalinao, Yilong Zou, Katherine S. Panageas, Craig Nolan, Igor T. Gavrilovic and Thomas Kaley and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Blood.

In The Last Decade

Elena Pentsova

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elena Pentsova United States 18 869 645 500 474 409 67 1.5k
Igor T. Gavrilovic United States 15 1.2k 1.4× 858 1.3× 537 1.1× 705 1.5× 496 1.2× 42 2.0k
Sean Grimm United States 24 1.2k 1.4× 503 0.8× 416 0.8× 900 1.9× 562 1.4× 79 2.1k
Tiffany R. Hodges United States 19 722 0.8× 289 0.4× 280 0.6× 188 0.4× 283 0.7× 43 1.5k
Merideth M Wendland United States 15 825 0.9× 910 1.4× 477 1.0× 157 0.3× 151 0.4× 27 1.4k
René-Olivier Mirimanoff Switzerland 10 394 0.5× 327 0.5× 311 0.6× 192 0.4× 207 0.5× 15 899
Sarah Leary United States 22 911 1.0× 281 0.4× 268 0.5× 519 1.1× 87 0.2× 100 1.5k
Blanca Diez Argentina 19 1.1k 1.2× 387 0.6× 256 0.5× 497 1.0× 225 0.6× 40 1.5k
Nancy Garren United States 4 1.0k 1.2× 396 0.6× 266 0.5× 202 0.4× 74 0.2× 4 1.3k
Paul Duic United States 3 1.0k 1.2× 393 0.6× 254 0.5× 205 0.4× 75 0.2× 5 1.3k
Piergiorgio Modena Italy 21 370 0.4× 633 1.0× 336 0.7× 225 0.5× 309 0.8× 43 1.9k

Countries citing papers authored by Elena Pentsova

Since Specialization
Citations

This map shows the geographic impact of Elena Pentsova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Pentsova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Pentsova more than expected).

Fields of papers citing papers by Elena Pentsova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Pentsova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Pentsova. The network helps show where Elena Pentsova may publish in the future.

Co-authorship network of co-authors of Elena Pentsova

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Pentsova. A scholar is included among the top collaborators of Elena Pentsova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Pentsova. Elena Pentsova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhun, Émilie Le, et al.. (2025). Point/Counterpoint: Intrathecal therapy for patients with leptomeningeal metastases from solid tumors. Neuro-Oncology. 27(9). 2225–2231.
2.
3.
Rhun, Émilie Le, Mary Jane Lim-Fat, Roberta Rudà, et al.. (2024). NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases. Neuro-Oncology. 27(2). 455–465. 1 indexed citations
4.
Grommes, Christian, Elena Pentsova, Lauren Schaff, et al.. (2023). Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma. Leukemia & lymphoma. 64(9). 1545–1553. 5 indexed citations
5.
Schaff, Lauren, Andrew Lin, Subhiksha Nandakumar, et al.. (2022). Combination Olaparib and Temozolomide for the Treatment of Glioma. Neurology. 99(17). 750–755. 7 indexed citations
6.
7.
Lin, Andrew, Alexandra Miller, Igor T. Gavrilovic, et al.. (2022). Concurrent Olaparib and Temozolomide for Recurrent Glioma (P5-9.005). Neurology. 98(18_supplement).
8.
Wijetunga, N. Ari, Alexander G. Goglia, Nils Weinhold, et al.. (2022). Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases. Clinical Cancer Research. 29(4). 775–783. 5 indexed citations
9.
Malani, Rachna, Martin Fleisher, Priya Kumthekar, et al.. (2020). Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer. Journal of Neuro-Oncology. 148(3). 599–606. 62 indexed citations
10.
Nevel, Kathryn, Elena Pentsova, & Mariza Daras. (2019). Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma. Leukemia & lymphoma. 60(7). 1677–1684. 14 indexed citations
11.
Morikawa, Aki, Elisa de Stanchina, Elena Pentsova, et al.. (2019). Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases. Clinical Cancer Research. 25(13). 3784–3792. 35 indexed citations
12.
Boire, Adrienne, et al.. (2017). Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell. 168(6). 1101–1113.e13. 238 indexed citations
13.
Diamond, Eli L., Katherine S. Panageas, Allison J. Applebaum, et al.. (2016). Frequency and Predictors of Acute Hospitalization Before Death in Patients With Glioblastoma. Journal of Pain and Symptom Management. 53(2). 257–264. 25 indexed citations
14.
Grommes, Christian, Igor T. Gavrilovic, Thomas Kaley, et al.. (2016). Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL). Annals of Oncology. 27. vi105–vi105. 13 indexed citations
15.
Pentsova, Elena, et al.. (2016). Phase II study of single agent buparlisib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL). Annals of Oncology. 27. vi106–vi106. 21 indexed citations
16.
Morikawa, Aki, et al.. (2016). Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis. Clinical Breast Cancer. 17(1). 23–28. 78 indexed citations
17.
Nayak, Lakshmi, Katherine S. Panageas, Anne S. Reiner, et al.. (2015). Radiotherapy and temozolomide for anaplastic astrocytic gliomas. Journal of Neuro-Oncology. 123(1). 129–134. 4 indexed citations
18.
Pentsova, Elena, Lisa M. DeAngelis, & Antonio Omuro. (2014). Methotrexate re-challenge for recurrent primary central nervous system lymphoma. Journal of Neuro-Oncology. 117(1). 161–165. 74 indexed citations
19.
Spratt, Daniel E., Michael R. Folkert, Zachary S. Zumsteg, et al.. (2013). Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma. Journal of Neuro-Oncology. 116(2). 357–363. 39 indexed citations
20.
Gorovets, Daniel, Kasthuri Kannan, Ronglai Shen, et al.. (2012). IDH Mutation and Neuroglial Developmental Features Define Clinically Distinct Subclasses of Lower Grade Diffuse Astrocytic Glioma. Clinical Cancer Research. 18(9). 2490–2501. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Igor T. Gavrilovic Breakdown of academic impact, for papers by Sean Grimm Breakdown of academic impact, for papers by Tiffany R. Hodges Breakdown of academic impact, for papers by Merideth M Wendland Breakdown of academic impact, for papers by René-Olivier Mirimanoff Breakdown of academic impact, for papers by Sarah Leary Breakdown of academic impact, for papers by Blanca Diez Breakdown of academic impact, for papers by Nancy Garren Breakdown of academic impact, for papers by Paul Duic Breakdown of academic impact, for papers by Piergiorgio Modena
Rankless by CCL
2026